Rutherford 2 mean change in ldl c levels with evolocumab or placebo biweekly or monthly in hefh
This presentation is the property of its rightful owner.
Sponsored Links
1 / 1

Change from baseline in LDL cholesterol (%) PowerPoint PPT Presentation


  • 40 Views
  • Uploaded on
  • Presentation posted in: General

RUTHERFORD-2: mean change in LDL-c levels with evolocumab or placebo biweekly or monthly in HeFH. Change from baseline in LDL cholesterol (%). Raal et al., The Lancet Oct 2014.

Download Presentation

Change from baseline in LDL cholesterol (%)

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Rutherford 2 mean change in ldl c levels with evolocumab or placebo biweekly or monthly in hefh

RUTHERFORD-2: mean change in LDL-c levels with evolocumab or placebo biweekly or monthly in HeFH

Change from baseline in LDL cholesterol (%)

Raal et al., The Lancet Oct 2014


  • Login